Credit Suisse’s Lipocine LPCN Stock Holding History

Credit Suisse’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-706	Closed	-$17K	–	4396
2020 Q3	$17K	Buy	+706	New	+$18.7K	﹤0.01%	3992
2017 Q3	–	Sell	-1,864	Closed	-$127K	–	4229
2017 Q2	$127K	Buy	+1,864	New	+$122K	﹤0.01%	3699
2017 Q1	–	Sell	-608	Closed	-$38K	–	3949
2016 Q4	$38K	Buy	+608	New	+$38.5K	﹤0.01%	4040
2016 Q2	–	Sell	-2,155	Closed	-$372K	–	4284
2016 Q1	$372K	Buy	2,155 +1,478	+218%	+$252K	﹤0.01%	3408
2015 Q4	$149K	Buy	+677	New	+$142K	﹤0.01%	3995

Other funds holding LPCN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's LPCN Position: Q4 2020 in Review

Credit Suisse sold out of Lipocine (LPCN) in Q4 2020, closing a stake of 706 shares — an estimated $17K sold.

Credit Suisse first reported a position in LPCN in Q4 2015 and held it in 5 quarters. The position peaked at $372K in Q1 2016. 33 funds tracked by Wall St. Rank hold LPCN as of Q4 2020.

Credit Suisse reported no remaining Lipocine position as of Q4 2020 after selling out during the quarter.
Credit Suisse sold 706 Lipocine shares in Q4 2020, an estimated $17K.
Credit Suisse first reported a position in Lipocine in Q4 2015 and held it in 5 quarters.
Credit Suisse's Lipocine position peaked at $372K in Q1 2016.
33 funds tracked by Wall St. Rank held Lipocine as of Q4 2020.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.